Status:
COMPLETED
The Clinical Efficacy of Recently Developed Supraglottic Airway Device, I-gel™, in Neonates and Infants: Comparison With Classic-laryngeal Mask Airway (c-LMA)
Lead Sponsor:
Yonsei University
Conditions:
Airway Complication of Anaesthesia
Eligibility:
All Genders
Up to 1 years
Phase:
NA
Brief Summary
Although the safety and efficacy of the Classic-laryngeal mask airway (c-LMA) in children has been shown in several large observational studies, findings suggest that the smaller-sized c-LMAs, in part...
Eligibility Criteria
Inclusion
- infants (0-1 year of age)
- who scheduled for elective surgery of short duration (less than 2 hr) undergoing general anesthesia using supraglottic airway
Exclusion
- patients with an abnormal airway
- with reactive airway disease
- with gastroesophageal reflux disease
- with chronic respiratory disease
- has a history of an upper respiratory tract infection in the preceding 6-week period
Key Trial Info
Start Date :
September 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2013
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT01437137
Start Date
September 1 2011
End Date
January 1 2013
Last Update
June 4 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Severance Hospital
Seoul, Seoul, South Korea, 120-752